Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07114172

Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volunteers

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

This is a small-sample safety study involving 15 healthy volunteers who were divided into groups and underwent 68Ga-ACC-DE, 68Ga-FASN-DE, and 68Ga-ACLY-DE PET/CT imaging for safety, biodistribution, and radiation dosimetry assessments, laying the foundation for subsequent studies on the efficacy of resistance monitoring in melanoma targeted therapy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST68Ga-ACC-DE/68Ga-FASN-DE/68Ga-ACLY-DE PET/CTRecruit 15 healthy adult volunteers, divided into three groups, to undergo dynamic PET/CT (1 hour) and static PET/CT (2 hours and 3 hours) imaging with 68Ga-ACC-DE, 68Ga-FASN-DE, or 68Ga-ACLY-DE, respectively, to assess safety, biodistribution, and radiation dosimetry, laying the foundation for subsequent studies.

Timeline

Start date
2025-08-15
Primary completion
2025-10-15
Completion
2025-10-15
First posted
2025-08-11
Last updated
2025-08-11

Source: ClinicalTrials.gov record NCT07114172. Inclusion in this directory is not an endorsement.

Study of Melanoma-Resistant PET Monitoring Based on Key Rate-limiting Enzymes for Fatty Acid Metabolism in Healthy Volun (NCT07114172) · Clinical Trials Directory